Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer.
Wang L, Li H, Yang S, Ma W, Liu M, Guo S, Zhan J, Zhang H, Tsang SY, Zhang Z, Wang Z, Li X, Guo YD, Li X.
Wang L, et al. Among authors: wang z.
Oncotarget. 2016 Oct 18;7(42):68864-68882. doi: 10.18632/oncotarget.12025.
Oncotarget. 2016.
PMID: 27655695
Free PMC article.